A.P. Moller Holding rejects future life science investments despite record-breaking purchase
In spite of the fact that A.P. Moller Holding announced its biggest acquisition ever on Friday, purchasing laboratory diagnostics firm Unilabs, the rest of the industry should not hold its breath over a similar investment. "We are not currently working on life science investments," says A.P. Moller Holding's CIO.
by christopher due karlsson, translated by daniel pedersen
On Friday, A.P. Moller Holding revealed plans pertaining to the acquisition of laboratory diagnostics firm Unilabs. However, the arrival of the major investment firm does not herald change for the life science industry.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
A.P. Moller Holding set to acquire Unilabs
For subscribers
